High-dose tamoxifen and sulindac as first-line treatment for desmoid tumors.
N Julian H
NJ
Sturt
Robin K S
RK
Phillips
Susan K
SK
Clark
D000008:Abdominal Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D000293:Adolescent; D000971:Antineoplastic Combined Chemotherapy Protocols; D002648:Child; D002675:Child, Preschool; D015331:Cohort Studies; D004305:Dose-Response Relationship, Drug; D005260:Female; D018222:Desmoid Tumors / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D006801:Humans; D008297:Male; D020714:Maximum Tolerated Dose; D011379:Prognosis; D018570:Risk Assessment; D013467:Sulindac / Q000008:administration & dosage*; D016019:Survival Analysis; D013629:Tamoxifen / Q000008:administration & dosage*; D016896:Treatment Outcome
D013629:Tamoxifen; D013467:Sulindac